|
1
|
- Dawn Schaefer RN BSN
- West De Pere District Nurse
|
|
2
|
- Adolescents and college students at increased risk
- Disease progresses rapidly and within hours can lead to permanent
disability or death
- May be prevented through immunization
|
|
3
|
- Bacterial infection caused by the bacterium Neisseria meningitidis
- Leading cause of bacterial meningitis among U.S. toddlers, children and
adolescents
- Attacks membranes surrounding the brain and spinal cord (meningitis) or
poisons the blood (meningococcemia)
|
|
4
|
- Strikes approximately 3,000 Americans each year; 10% of them will die
- Among teenagers and college students, fatality rate is unusually high
- According to one study, as many as one in four teens who contract the
disease may die
- Disease can progress rapidly and symptoms may resemble those of common
viral illnesses:
- High fever
- Headache
- Nausea
- Exhaustion
- Rash
|
|
5
|
- Nearly 20% of meningococcal disease survivors have permanent
disabilities, including:
- Brain damage
- Loss of hearing
- Organ failure
- Limb amputations
|
|
6
|
- Meningococcal bacteria are transmitted through air droplets and/or by
direct contact with secretions from infected persons (e.g., through
coughing or kissing)
- The majority of meningococcal disease cases occur in winter and early
spring
|
|
7
|
- Five serogroups, or strains of the bacteria, cause 95% of meningococcal
cases worldwide
- A, B, C, Y and W-135
- Serogroups B,C and Y are most prevalent in the U.S.
- Among teenagers and young adults, up to 83% of cases may be prevented
through immunization
|
|
8
|
|
|
9
|
- Vaccination
- Most effective method of protection
- Immunization may prevent up to 83% of cases occurring among teenagers
and college students
- Encouraging healthy habits
- Promote frequent hand-washing and good hygiene
- Avoid sharing items that touch a person’s mouth, since it may help
spread the disease
- Encourage teens and young adults to get enough sleep and maintain a
healthy lifestyle
|
|
10
|
- FDA-approved conjugate meningococcal vaccine expected to provide longer
term protection against disease
- Protects against 4 of the 5 serogroups (A,C,Y, W-135)
- Available for use in persons 11 to 55 years
|
|
11
|
- The Centers for Disease Control and Prevention (CDC) recommends
vaccination for:
- Adolescents at preadolescent doctor’s visit (11-12 years)
- Adolescents at high school entry, or about age 15
- College freshmen living in dormitories
- Other groups at high risk (e.g., travellers, military recruits, complement
deficient and asplenic patients)
- Other adolescents who wish to decrease their risk of meningococcal
disease may choose to be immunized
|
|
12
|
- Support efforts to educate parents and students about the disease and
immunization
- To reach the community with this important information, we plan to:
- Distribute letters to parents
- Post posters/information throughout the school
- Conduct presentations at back-to-school/parents nights
- Reach out to the health department to host a vaccination clinic
|
|
13
|
- Talk to your family’s health care provider to see if your child should
be vaccinated
- To learn more about meningococcal disease and prevention, contact Dawn
Schaefer RN West De Pere District Nurse at 337-1087 ext. 8031.
|